Deva Holding AS | 应收帐款人

股票价格
78.00
每天变化
-2.65 -3.29%
每月一次
22.74%
每年
13.87%
Q1 预测
71.37


金融业
股票价格
TRY
资产
TRY 12.93B
现金及等价物
TRY 775.92M
销售成本
TRY 991.13M
流动资产
TRY 9.13B
流动负债
TRY 6.43B
债务
TRY 5.3B
股息收益率
0.18
EBIT
TRY 820.88M
EBITDA
TRY 882.9M
EPS每股收益
TRY 2.92
股本和储备
TRY 5.79B
销售毛利
TRY 1.32B
债务利息支出
TRY 272.53M
贷款资金
TRY 559.97M
市值
TRY 14.89B
净收入
TRY 583.98M
营业费用
TRY 1.35B
营业利润
TRY 964.87M
普通股股本
TRY 200.02M
PE价格收益
6.55
销售收入
TRY 2.32B
销售和管理费用
TRY 462.26M
贸易债权人
TRY 809.81M
应收帐款人
TRY 3.03B


应收帐款人 更改 日
Akebia Therapeutics USD 61.54M 27.17M 2025-03
Alaunos Therapeutics USD 2K 0 2025-06
Avita Medical AUD 11.37M 593K 2025-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 5M 4.96M 2025-09
Ionis Pharmaceuticals USD 24.61M 27.97M 2025-09
IQVIA Holdings USD 3.43B 113M 2025-12
Moderna USD 184M 862M 2025-12
Organon & Co USD 1.48B 0 2025-09
Revvity USD 744.67M 64.41M 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Viatris USD 3.37B 225.7M 2025-09
Xeris Pharmaceuticals USD 53.75M 700K 2025-09


Deva Holding AS 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.